Cleared Traditional

K882811 - STREPSLIDE

K882811 is the FDA 510(k) clearance for STREPSLIDE by Ncs Diagnostics, Inc.. It is a Class 1 Microbiology device (product code GTY) cleared through the Traditional 510(k) pathway after a 110-day FDA review.

K882811 · Ncs Diagnostics, Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1988
Decision
110d
Days
Class 1
Risk

K882811 is an FDA 510(k) clearance for the STREPSLIDE. Classified as Antigens, All Groups, Streptococcus Spp. (product code GTY), Class I - General Controls.

Submitted by Ncs Diagnostics, Inc. (Mississauga, L4z 1y6, CA). The FDA issued a Cleared decision on October 25, 1988 after a review of 110 days - within the typical 510(k) review window.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3740 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Ncs Diagnostics, Inc. devices

Submission Details

510(k) Number K882811 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 07, 1988
Decision Date October 25, 1988
Days to Decision 110 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
8d slower than avg
Panel avg: 102d · This submission: 110d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code GTY Antigens, All Groups, Streptococcus Spp.
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3740
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - GTY Antigens, All Groups, Streptococcus Spp.

All 29
Devices cleared under the same product code (GTY) and FDA review panel - the closest regulatory comparables to K882811.
SLIDEX STREPTO-KIT
K905020 · Vitek Systems, Inc. · Jan 1991
KODAK SURECELL(TM) STREP A CONTROL FLUID SET
K904589 · Eastman Kodak Company · Jan 1991
ICON STREP B IMMUNOENZYMETRIC ASSAY
K902991 · Hybritech, Inc. · Oct 1990
ABBOTT TESTPACK(TM) STREP A POSITIVE CONTROL
K864752 · Abbott Laboratories · Feb 1987
PHADEBACT CSF POSITIVE CONTROLS
K840048 · Pharmacia, Inc. · Mar 1984
PHADEBACT STREP POSITIVE CONTROLS
K832248 · Pharmacia, Inc. · Sep 1983